Upcoming Oral Arguments in BPCIA Litigation

Amgen v. Hospira (epoetin alfa)  •  Amgen v. Sandoz (filgrastim)  •  U.S. Biosimilar Litigation News

On Friday, the United States Supreme Court set oral arguments in Amgen v. Sandoz for April 26, 2017.

Today, the United States Court of Appeals for the Federal Circuit announced that oral arguments in Amgen v. Hospira will be held on April 3, 2017.

Stay tuned to Big Molecule Watch for further updates.  For background on these and other cases, visit our BPCIA Litigation Summary Chart.

Download PDF

Comments are closed.